145 related articles for article (PubMed ID: 37658133)
1. Aspects for development of novel antibacterial medicines using a vitamin D
Wanibuchi K; Hosoda K; Amgalanbaatar A; Ihara M; Takezawa M; Sakai Y; Masui H; Shoji M; Hayashi S; Shimomura H
J Antibiot (Tokyo); 2023 Nov; 76(11):665-672. PubMed ID: 37658133
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial effect of indene on Helicobacter pylori correlates with specific interaction between its compound and dimyristoyl-phosphatidylethanolamine.
Wanibuchi K; Takezawa M; Hosoda K; Amgalanbaatar A; Tajiri K; Koizumi Y; Niitsu S; Masui H; Sakai Y; Shoji M; Takahashi T; Hirai Y; Shimomura H
Chem Phys Lipids; 2020 Mar; 227():104871. PubMed ID: 31923389
[TBL] [Abstract][Full Text] [Related]
3. Indene Compounds Synthetically Derived from Vitamin D Have Selective Antibacterial Action on Helicobacter pylori.
Wanibuchi K; Hosoda K; Ihara M; Tajiri K; Sakai Y; Masui H; Takahashi T; Hirai Y; Shimomura H
Lipids; 2018 Apr; 53(4):393-401. PubMed ID: 29766504
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a vitamin D₃ decomposition product bactericidal against Helicobacter pylori.
Hosoda K; Shimomura H; Wanibuchi K; Masui H; Amgalanbaatar A; Hayashi S; Takahashi T; Hirai Y
Sci Rep; 2015 Mar; 5():8860. PubMed ID: 25749128
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D3 activates the autolysosomal degradation function against Helicobacter pylori through the PDIA3 receptor in gastric epithelial cells.
Hu W; Zhang L; Li MX; Shen J; Liu XD; Xiao ZG; Wu DL; Ho IHT; Wu JCY; Cheung CKY; Zhang YC; Lau AHY; Ashktorab H; Smoot DT; Fang EF; Chan MTV; Gin T; Gong W; Wu WKK; Cho CH
Autophagy; 2019 Apr; 15(4):707-725. PubMed ID: 30612517
[TBL] [Abstract][Full Text] [Related]
6. Unique responses of Helicobacter pylori to exogenous hydrophobic compounds.
Shimomura H; Wanibuchi K; Hosoda K; Amgalanbaatar A; Masui H; Takahashi T; Hirai Y
Chem Phys Lipids; 2020 Jul; 229():104908. PubMed ID: 32259519
[TBL] [Abstract][Full Text] [Related]
7. In vitro antibacterial activity of Phx-3 against Helicobacter pylori.
Hanawa T; Osaki T; Manzoku T; Fukuda M; Kawakami H; Tomoda A; Kamiya S
Biol Pharm Bull; 2010; 33(2):188-91. PubMed ID: 20118538
[TBL] [Abstract][Full Text] [Related]
8. In vitro anti-bactrical activity and its preliminary mechanism of action of the non-medicinal parts of Sanguisorba officinalis L. against Helicobacter pylori infection.
Chen P; Chen M; Peng C; Yan J; Shen X; Zhang W; Yuan Y; Gan G; Luo X; Zhu W; Yao M
J Ethnopharmacol; 2024 Jan; 318(Pt B):116981. PubMed ID: 37574016
[TBL] [Abstract][Full Text] [Related]
9. The synergistic effect of
Nabavi-Rad A; Jamshidizadeh S; Azizi M; Yadegar A; Robinson K; Monaghan TM; Zali MR
Front Cell Infect Microbiol; 2023; 13():1171469. PubMed ID: 37216180
[TBL] [Abstract][Full Text] [Related]
10. In vitro antibacterial activity of nimbolide against Helicobacter pylori.
Wylie MR; Windham IH; Blum FC; Wu H; Merrell DS
J Ethnopharmacol; 2022 Mar; 285():114828. PubMed ID: 34763046
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo anti-Helicobacter pylori activity of Casearia sylvestris leaf derivatives.
Spósito L; Oda FB; Vieira JH; Carvalho FA; Dos Santos Ramos MA; de Castro RC; Crevelin EJ; Crotti AEM; Santos AG; da Silva PB; Chorilli M; Bauab TM
J Ethnopharmacol; 2019 Apr; 233():1-12. PubMed ID: 30594606
[TBL] [Abstract][Full Text] [Related]
12. Potent antibacterial activity of Y-754, a novel benzimidazole compound with selective action against Helicobacter pylori.
Iwao E; Yamamoto K; Yokoyama Y; Hirayama F; Haga K
J Infect Chemother; 2004 Apr; 10(2):90-6. PubMed ID: 15160301
[TBL] [Abstract][Full Text] [Related]
13. In-vitro anti-Helicobacter pylori activity and preliminary mechanism of action of Canarium album Raeusch. fruit extracts.
Yan J; Peng C; Chen P; Zhang W; Jiang C; Sang S; Zhu W; Yuan Y; Hong Y; Yao M
J Ethnopharmacol; 2022 Jan; 283():114578. PubMed ID: 34464702
[TBL] [Abstract][Full Text] [Related]
14. Steroids mediate resistance to the bactericidal effect of phosphatidylcholines against Helicobacter pylori.
Shimomura H; Hosoda K; Hayashi S; Yokota K; Oguma K; Hirai Y
FEMS Microbiol Lett; 2009 Nov; 301(1):84-94. PubMed ID: 19843309
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial activity of a novel synthetic progesterone species carrying a linoleic acid molecule against Helicobacter pylori and the hormonal effect of its steroid on a murine macrophage-like cell line.
Amgalanbaatar A; Shimomura H; Hosoda K; Hayashi S; Yokota K; Hirai Y
J Steroid Biochem Mol Biol; 2014 Mar; 140():17-25. PubMed ID: 24189541
[TBL] [Abstract][Full Text] [Related]
16. Anti-Helicobacter pylori potential of artemisinin and its derivatives.
Goswami S; Bhakuni RS; Chinniah A; Pal A; Kar SK; Das PK
Antimicrob Agents Chemother; 2012 Sep; 56(9):4594-607. PubMed ID: 22687518
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and bioevaluation of novel 3,4,5-trimethoxybenzylbenzimidazole derivatives that inhibit Helicobacter pylori-induced pathogenesis in human gastric epithelial cells.
Chang CS; Liu JF; Lin HJ; Lin CD; Tang CH; Lu DY; Sing YT; Chen LY; Kao MC; Kuo SC; Lai CH
Eur J Med Chem; 2012 Feb; 48():244-54. PubMed ID: 22217866
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Structure-Activity Relationship of Palmatine Derivatives as a Novel Class of Antibacterial Agents against
Fan T; Guo X; Zeng Q; Wei W; You X; Wang Y; Pang J; Song D
Molecules; 2020 Mar; 25(6):. PubMed ID: 32188132
[TBL] [Abstract][Full Text] [Related]
19. New Silver(I) Coordination Compound Loaded into Polymeric Nanoparticles as a Strategy to Improve
Almeida Furquim de Camargo B; Soares Silva DE; Noronha da Silva A; Campos DL; Machado Ribeiro TR; Mieli MJ; Borges Teixeira Zanatta M; Bento da Silva P; Pavan FR; Gallina Moreira C; Resende FA; Menegário AA; Chorilli M; Vieira de Godoy Netto A; Bauab TM
Mol Pharm; 2020 Jul; 17(7):2287-2298. PubMed ID: 32515970
[No Abstract] [Full Text] [Related]
20. In vitro anti-Helicobacter pylori activity of Syzygium aromaticum and the preliminary mechanism of action.
Peng C; Sang S; Shen X; Zhang W; Yan J; Chen P; Jiang C; Yuan Y; Zhu W; Yao M
J Ethnopharmacol; 2022 Apr; 288():114995. PubMed ID: 35032584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
